While these findings provide a strong foundation for the role of Mel in regulating COX‐2‐related signalling, the potential of Mel as a chemosensitiser in GBM—especially in TMZ‐resistant settings—has not been thoroughly explored. This evidence concerns the gene PTGS2 and glioblastoma.